Eli Lilly subsidiary ends lucrative collaboration with Durham biotech

The deal included milestone payments up to nearly $400 million for Precision BioSciences.

Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: Zac Ezzone Source Type: news